| Date | Title | Description | |
|---|---|---|---|
| 12 Mar 2024 | On business and financial situation | ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies | Download |
| 08 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 1 March and 7 March 2024 | Download |
| 07 Mar 2024 | On corporate transactions | ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives | Download |
| 01 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 23 February and 29 February 2024 | Download |
| 27 Feb 2024 | Annual Financial Reports and Audit Reports | The Company submits the 2023 Annual Financial Report | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 31 May 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI releases the information related to its General Shareholders Meeting | Download |
| 26 Apr 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI informs about the call for the 2017 Ordinary General Shareholders Meeting | Download |
| 21 Apr 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI informs about the call for the General Shareholders Meeting | Download |
| 21 Apr 2017 | Información sobre resultados | ROVI releases the press release related to the 2017 first quarter results. | Download |
| 21 Apr 2017 | Información sobre resultados | ROVI releases the presentation related to the 2017 first quarter results | Download |